Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease

BACKGROUND: Non-diabetic overweight/obese metabolic dysfunction-associated fatty liver disease (MAFLD) represents the largest subgroup with heterogeneous liver fibrosis risk. Metabolic dysfunction promotes liver fibrosis. Here, we investigated whether incorporating additional metabolic risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chi-Ho, Lui, David Tak-Wai, Li, Raymond Hang-Wun, Yuen, Michele Mae-Ann, Fong, Carol Ho-Yi, Leung, Ambrose Pak-Wah, Chu, Justin Chiu-Man, Mak, Loey Lung-Yi, Lam, Tai-Hing, Woo, Jean, Woo, Yu-Cho, Xu, Aimin, Tse, Hung-Fat, Tan, Kathryn Choon-Beng, Cheung, Bernard Man-Yung, Yuen, Man-Fung, Lam, Karen Siu-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853017/
https://www.ncbi.nlm.nih.gov/pubmed/36686469
http://dx.doi.org/10.3389/fendo.2022.1056562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853017/
https://www.ncbi.nlm.nih.gov/pubmed/36686469
http://dx.doi.org/10.3389/fendo.2022.1056562

Ejemplares similares